Institutional investors control 12.65% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $24.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FONDSFINANS KAPITALFORVALTNING A... Bought 3.1 Thousand shares of GlaxoSmithKline PLC
HARVEST PORTFOLIOS GROUP, INC. Bought 2.6 Thousand shares of GlaxoSmithKline PLC
EVOLUTION CAPITAL MANAGEMENT LLC Bought 467.00 shares of GlaxoSmithKline PLC